Clinical trial
PROFIT - Prostate Fractionated Irradiation Trial
NCT00304759 · Ontario Clinical Oncology Group (OCOG), Other · Completed
Key facts
| NCT number | NCT00304759 |
|---|---|
| Title | PROFIT - Prostate Fractionated Irradiation Trial |
| Official title | A Randomized Trial of a Shorter Radiation Fractionation Schedule for the Treatment of Localized Prostate Cancer |
| Lead sponsor | Ontario Clinical Oncology Group (OCOG), Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) Trans Tasman Radiation Oncology Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Procedure |
| Interventions | 7800 cGy/39 fractions in 8 weeks, 6000 cGy/20 fractions in 4 weeks |
| Enrollment | 1,204 |
| Start date | May 1, 2006 |
| Primary completion | Jul 15, 2017 |
| Completion | Jul 15, 2017 |
| First posted | Mar 20, 2006 |
| Last update posted | Jul 31, 2017 |
| Countries | Australia, Canada, France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: